vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and SYNAPTICS Inc (SYNA). Click either name above to swap in a different company.
SYNAPTICS Inc is the larger business by last-quarter revenue ($302.5M vs $207.8M, roughly 1.5× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -4.9%, a 62.3% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $18.2M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Synaptics, Inc. is an American neural network technologies and computer-to-human interface devices development company based in San Jose, California. It develops touchpads and fingerprint biometrics technology for computer laptops; touch, display driver, and fingerprint biometrics technology for smartphones; and touch, video and far-field voice, low-power AI processors, and wireless technology for smart home devices, wearables, and automobiles. Synaptics sells its products to original equipme...
IDYA vs SYNA — Head-to-Head
Income Statement — Q3 FY2025 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $207.8M | $302.5M |
| Net Profit | $119.2M | $-14.8M |
| Gross Margin | — | 43.5% |
| Operating Margin | 52.2% | -5.0% |
| Net Margin | 57.4% | -4.9% |
| Revenue YoY | — | 13.2% |
| Net Profit YoY | 330.1% | -922.2% |
| EPS (diluted) | $1.33 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $302.5M | ||
| Q3 25 | $207.8M | $292.5M | ||
| Q2 25 | — | $282.8M | ||
| Q1 25 | — | $266.6M | ||
| Q4 24 | — | $267.2M | ||
| Q3 24 | $0 | $257.7M | ||
| Q2 24 | $0 | $247.4M | ||
| Q1 24 | $0 | $237.3M |
| Q4 25 | — | $-14.8M | ||
| Q3 25 | $119.2M | $-20.6M | ||
| Q2 25 | — | $-4.7M | ||
| Q1 25 | — | $-21.8M | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | $-51.8M | $-23.1M | ||
| Q2 24 | $-52.8M | $208.3M | ||
| Q1 24 | $-39.6M | $-18.1M |
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 42.6% | ||
| Q2 25 | — | 43.0% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | — | 46.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | 46.5% |
| Q4 25 | — | -5.0% | ||
| Q3 25 | 52.2% | -7.9% | ||
| Q2 25 | — | -8.6% | ||
| Q1 25 | — | -9.9% | ||
| Q4 24 | — | -5.7% | ||
| Q3 24 | — | -11.0% | ||
| Q2 24 | — | -12.6% | ||
| Q1 24 | — | -7.3% |
| Q4 25 | — | -4.9% | ||
| Q3 25 | 57.4% | -7.0% | ||
| Q2 25 | — | -1.7% | ||
| Q1 25 | — | -8.2% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | -9.0% | ||
| Q2 24 | — | 84.2% | ||
| Q1 24 | — | -7.6% |
| Q4 25 | — | $-0.38 | ||
| Q3 25 | $1.33 | $-0.53 | ||
| Q2 25 | — | $-0.13 | ||
| Q1 25 | — | $-0.56 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.60 | $-0.58 | ||
| Q2 24 | $-0.68 | $5.28 | ||
| Q1 24 | $-0.53 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $437.4M |
| Total DebtLower is stronger | — | $836.0M |
| Stockholders' EquityBook value | $1.1B | $1.4B |
| Total Assets | $1.2B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $437.4M | ||
| Q3 25 | $786.9M | $459.9M | ||
| Q2 25 | — | $452.5M | ||
| Q1 25 | — | $421.4M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | $920.0M | $853.6M | ||
| Q2 24 | $701.7M | $876.9M | ||
| Q1 24 | $698.8M | $828.6M |
| Q4 25 | — | $836.0M | ||
| Q3 25 | — | $835.4M | ||
| Q2 25 | — | $834.8M | ||
| Q1 25 | — | $834.2M | ||
| Q4 24 | — | $832.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $983.5M | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $931.7M | $1.5B | ||
| Q1 24 | $935.3M | $1.2B |
| Q4 25 | — | $2.6B | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.5B | ||
| Q3 24 | $1.2B | $2.8B | ||
| Q2 24 | $973.7M | $2.8B | ||
| Q1 24 | $961.5M | $2.5B |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 0.60× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $29.8M |
| Free Cash FlowOCF − Capex | $142.2M | $18.2M |
| FCF MarginFCF / Revenue | 68.4% | 6.0% |
| Capex IntensityCapex / Revenue | 0.0% | 3.8% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $154.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $29.8M | ||
| Q3 25 | $142.2M | $30.2M | ||
| Q2 25 | — | $57.2M | ||
| Q1 25 | — | $73.4M | ||
| Q4 24 | — | $22.8M | ||
| Q3 24 | $-49.2M | $-11.4M | ||
| Q2 24 | $-32.9M | $65.0M | ||
| Q1 24 | $-43.8M | $-13.7M |
| Q4 25 | — | $18.2M | ||
| Q3 25 | $142.2M | $18.0M | ||
| Q2 25 | — | $50.6M | ||
| Q1 25 | — | $68.0M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | $-49.7M | $-20.5M | ||
| Q2 24 | $-33.9M | $57.3M | ||
| Q1 24 | $-45.1M | $-22.7M |
| Q4 25 | — | 6.0% | ||
| Q3 25 | 68.4% | 6.2% | ||
| Q2 25 | — | 17.9% | ||
| Q1 25 | — | 25.5% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | — | -8.0% | ||
| Q2 24 | — | 23.2% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 3.8% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 12.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDYA
Segment breakdown not available.
SYNA
| Enterprise And Automotive Product Applications | $161.1M | 53% |
| Internet Of Things Product Applications | $93.2M | 31% |
| Mobile Product Applications | $48.2M | 16% |